Back to search

Article

Inhibition of UBE2N in regulatory T-cells boosts immunity against cancer

2024-10-25

Abstract excerpt

Regulatory T (Treg) cells prevent autoimmunity and facilitate cancer immune evasion. Depletion of Tregs is a promising cancer therapy, but risks of autoimmune reactions hamper its clinical translation. Here, we demonstrate that temporally induced deletion of Ube2n in Tregs (Ube2n Treg-KO ) of adult mice results in a robust expansion and activation of cytotoxic CD8 + T-cells in response to cancer cell challenges,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5ad7ad40-eab8-572e-9853-29eea309c997
DOI
10.1101/2024.10.22.619436
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inhibition of UBE2N in regulatory T-cells boosts immunity against cancerDOI 10.1101/2024.10.22.619436
Select a neighboring publication to make it the new centre.